Stable expression of G protein coupled receptors in cell lines is a crucial tool for the characterization of the molecular pharmacology of receptors and the screening for new antagonists. However, in some instances, many difficulties have been encountered to obtain stable cell lines expressing functional receptors. Here, we addressed the question of vector optimization to establish cell lines expressing the human neuropeptide Y receptor 5 (NPY5-R) or histamine receptor 4 (HH4R). We have compared bicistronic vectors containing viral or cellular Internal Ribosome Entry Sites (IRES), co-expressing the receptor and the neomycine resistance gene from a single mRNA, to a bigenic vector containing two distinct promoters upstream each different genes. This study is the first one to validate the use of three cellular IRESs for long term transgene expression. Our results demonstrate for both NPY5-R and HH4R that the bicistronic vectors with EMCV, VEGF, FGF1A or FGF2 IRES provide clones expressing functional receptors with yields between 25% and 100%. In contrast, the bigenic vector provided no functional clones, related to a low expression of NPY5R mRNA. The cell lines expressing active receptor were stable after more than 50 passages. These data indicate that IRES-based bicistronic vectors are particularly appropriate to establish cell clones expressing active G-coupled protein receptors with a high yield. In the case of NPY5, it was a new way to produce such a stable cell line. Furthermore, the characteristics -presented herein -of this receptor pharmacological property are perfectly in line with those reported in the literature.
INTRODUCTION
Histamine and Neuropeptide Y receptors belong to the large family of seven transmembrane domains, G-protein coupled receptors. Three major functions for histamine, inflammatory wheal, gastric acid secretion in the gut and neurotransmitter release in the central nervous system, have been related to the H1, H2 and H3 receptor subtypes, respectively [1] . More recently, a fourth histamine receptor, H4 (HH4R), has been discovered, which, in view of its distribution might be involved in immune response. As regards to the neuropeptide Y (NPY), several receptors have been described [2] . NPY is a 36-amino acid peptide which belongs to the pancreatic polypeptide (PP) family [3] . NPY, expressed in the adrenal gland, exerts various auto-and paracrine regulatory functions. NPY is co-released with catecholamines under a variety of stimuli and stimulates catecholamines secretion while it inhibits aldosterone secretion. NPY may also be involved in the regulation of blood pressure and in the pathophysiology of pheochromocytomas. Among the NPY receptors, the receptor Y5 (NPY5-R) is claimed to be involved in feeding behavior in mammals.
The pharmacological interest of both HH4R and NPY5-R incited us to develop tools to establish their molecular pharmacology. However, difficulties have been encountered in obtaining stable cell lines expressing the human NPY5-R [4] as well as the human HH4R.
Such a lack of receptor expression in cell lines could result from inadequate intracellular targeting and/or counter-selection of cells expressing high levels of functional receptors.
Indeed, based on a long record of 7-transmembrane domain G-coupled receptor pharmacology studies in our lab, we established standard protocols, according to which most of our previous targets were obtained in stable expressing cell lines mainly CHO-derived, with some HEK ones. Our protocol included the adding of a M2 flag at the C-terminus of the receptor and the co-expression with a protein conferring neomycin resistance to the cells. This process was applied over the last years to bio-aminergic receptors, such as adrenoceptors 1 and 2 [5, 6] , melatoninergic receptors [7, 8] , MCH receptors [9, 10] , serotonin receptors [11] , histaminergic receptors [12] , a small bunch of enzymes [13, 14] and even some non-reported orphan receptors. In this strategy, we used a stable transfected Gα16-CHIO cell lines, which is useful in 'forcing' the secondary signals downstream the receptors towards the calcium release pathway. All along these years, we only found these two receptors (H4 and NPY5) to be resistant to this otherwise successful recipe. To be complete, we should point out that NPY5 has been reported expressed in a stable cell line, in the non-classical human endometrial cancer cell line HEC-1B [15] .
In order to overcome several attempts with our classical approaches that turned out all to be unsuccessful, we decided to focus on the basis of gene expression regulation. Expression cassettes may be improved by acting not only on the transcription control, but also on the translational control of the genes of interest. For a few years, research on translational control of gene expression has led, in particular, to the identification and characterization of RNA elements present in viral and cellular mRNAs, called IRESs (Internal Ribosome Entry Sites); they can be considered as translational enhancers [16, 17, 18, 19] . These elements have been identified in mRNAs bearing a long untranslated region (5' UTR) expected to prevent the translation initiation by classical cap-dependent mechanisms [20] . The first IRES's were discovered in two picornaviruses, poliovirus and encephalomyocarditis virus (EMCV) [16, 21] . The cellular mRNAs bearing IRES mostly encode for proteins involved in the growth control or stress response (for review, see [22] ). IRESs confer to these mRNAs the capability to be translated by a cap-independent mechanism when cap-dependent translation is blocked, which occurs during the M phase of cell cycle, and when cells are subjected to various stresses (heat shock, hypoxia, ischemia…).
The ability of IRESs to recruit ribosomes by an internal entry mechanism allows the design of expression cassettes in which a single transcription unit can code for several genes [23, 24] . Such a feature is not provided by the cap-dependent mechanism, according to which a given mRNA codes for a single protein. The multicistronic vector concept is possible only because of the introduction of IRESs between the genes borne by the multigenic expression cassette.
The use of multicistronic vectors provides several advantages by comparison with vectors comprising several promoters. Particularly, one expects to get rid of the promoter silencing phenomenon that often appears when several promoters are present, resulting in the loss of expression of counter-selected genes of interest.
In the cases of NPY5-R and HH4R, stable cell lines expressing functional forms of these receptors have not been obtained in our laboratory using classical vectors that proved to function on a wide variety of such receptors (vide supra). In the present study, we addressed this difficulty by constructing a set of bicistronic vectors expressing from a single promoter the receptor and the neomycine resistance gene under the control of different IRESs. Stable CHO clones expressing active NPY5-R and HH4R were obtained with a high yield using the bicistronic vectors with both viral and cellular IRESs, whereas no positive clones -as previously -were obtained when the receptor and resistance genes were expressed from monocistronic cassettes under the control of two distinct promoters.
MATERIALS AND METHODS.
Reagents -Peptides NPY were obtained from Neosystem (Illkirch, France), clobenpropit from Tocris (Avonmouth, UK). Histamine as well as forskolin, were obtained from SIGMA (St Louis, Mo). The human genes NPY5R and HRH4, flagged with the M2 sequence at the 3' terminal end, were from IdRS.
Vector construction -Plasmids used in this study and cloning strategies are available upon request. The oligonucleotides used to create the polylinker (SpeI -T3 PRIMER -HindIIINotI -SpeI -BamHI -NcoI -EcoRV -M13R PRIMER -BglII) had the following sequences: 5'ctagtATTAACCCTCACTAAAGGGAaagcttgcggccgcactagtggatccccatgggatatcGGTCATAGCTGTTTCCTGa3' (sense) ; 5'gatctCAGGAAACAGCTATGACCgatatcccatggggatccactagtgcggccgcaagcttTCCCTTTAGTGAGGGTTAATa3' (antisense).
Cell culture and transfection -Gα16-CHO cells derived from CHO cells were cultured in
Ham-F12 medium (Invitrogen, France) supplemented with 10% fetal calf serum and 200 µg/ml of hygromycin (Invitrogen, France) [10] . NPY5-R and HH4R were expressed in Gα16-CHO cells. Selection of Y5-Gα16-CHO or H4-Gα16-CHO cell clones was performed in complete Ham-F12 medium supplemented with 1,2 mg/ml geneticin and 100 g/ml hygromycin. Clones were further characterized by immunofluorescence using anti M2 flag
antibody. All cells were tested for the absence of mycoplasma contamination. Gα16-CHO cells were transfected with 2 µg total DNA for 65 000 cells per 3,5 cm diameter petri dishes, Immunohistochemistry of NPY5-R -In order to detect the NPY5-R protein in the absence of Y5 antibody, the NPY5R sequence was flanked with a M2 flag at the C terminal end.
Immunohistochemistry was performed as previously described [12] . Cells were cultivated in a glass-bottomed chamber for 24 hours, then fixed with 2% PFA and permeabilized with 0.1% 
RESULTS.

Bicistronic expression vectors with viral or cellular IRESs allow expression of functional
NPY5-R and HH4R. cDNAs encoding for the G-protein coupled receptors (GPCR) NPY5-R and HH4R, both flagged with M2 peptide at the C-terminus, were introduced into bicistronic vectors containing IRESs from different origins (Fig. 1A) . These vectors contained the receptor cDNA as a first cistron (cap dependent) and the G418 (neo) resistance gene as a second cistron (under the control of the IRES). By doing so, both the receptor and the neo genes are expressed from a single mRNA, which, in principle, guaranties the receptor expression in G418-resistant cells. The IRESs used were I) the EMCV IRES of viral origin and II) the VEGF, FGF1A and FGF2 IRESs of cellular origin. Indeed, most bicistronic vectors described in the literature so far contained the EMCV IRESs, whereas the cellular IRESs have never been used, except for the FGF2 [25] .
In parallel, the receptor cDNAs were also introduced into the pcDNA-3 vector, under the control of the CMV promoter, whereas the neo gene is controlled by the SV40 promoter (Fig. 1B) . In such a vector, the two genes are encoded by two distinct mRNAs. All these vectors were transfected into Gα16-CHO cells to obtain stable cellular clones in which calcium mobilization is forced by Gα16 protein to the studied receptor [26] [27] . Six cell clones expressing each bicistronic vector, and 12 clones expressing the so-called "bigenic"
pcDNA-3 derived vector, were analyzed for receptor binding and functionality.
In order to determine NPY5-R or HH4R functional activities for these different clones,
we measured the amount of cAMP produced by adenylate cyclase (AC) activity. In presence of forskolin (FK), AC activity leads to cAMP production. The receptor activation by its specific ligand, NPY for NPY5-R and histamine for HH4R, respectively, was expected to decrease the cAMP production due to the AC inhibition by a Gi protein. 2) . In contrast, no functional receptor was detected in any of the twelve cell clones expressing the pcDNA-derived bigenic vector. The receptor activity was also measured for clones expressing the HH4R (Fig. 3) . The results were similar: the bicistronic vectors allowed us to obtain, among six clone populations analyzed, six, four, three and one positive clones for the constructs with EMCV, VEGF, FGF1A and FGF2 IRESs, respectively. Six clones expressing the pcDNA-3 derived bigenic vector did not produce any functional HH4R.
These data showed, for NPY5-R and HH4R, striking differences in yield with bicistronic versus bigenic vectors: there was a 100% yield for EMCV IRES, 67% for VEGF IRES, 50% for FGF1A IRES and 13 to 25% for FGF2 IRES, while the yield was null for the two promoters-containing vectors.
The bicistronic vectors allow a higher receptor mRNA expression than the bigenic vector. In an attempt to explain the differences of active receptor expression between IRES-containing bicistronic vectors and two-promoters-containing bigenic vector, NPY5R amplicon was measured by quantitative RT PCR (Fig. 4) . The data show that the NPY5R mRNA copy number per ng of 18S RNA was comprised between 550 and 63000 for clones expressing the bicistronic vectors (producing functional receptor or not), whereas it was comprised between 0 and 450 for clones expressing the bigenic pcDNA-3 derived vectors. Thus, a first explanation for the absence of positive clones with the bigenic vector was a loss of expression of NPY5R amplicon, due to either interference between the two promoters or counterselection of the receptor-expressing clones.
However, another parameter probably also influenced the receptor activity in the different clones: with the bicistronic vectors, there was no correlation between the level of NPY5R mRNA expression and receptor activity (Fig. 4) . The clones expressing inactive receptor could be separated into two groups: the first one comprising clones 4 and 5 with FGF1A IRES and clone 6 with FGF2 IRES which express less than 1000 copies of NPY5R mRNA per ng of 18S RNA. In these clones, the absence of active receptor probably resulted from a poor expression of the receptor. In contrast, a second group of inactive clones expressed NPY5R mRNA at a level comparable to that of the active clones, comprised between 2860 and 15780 copies. The receptor inactivity for these clones cannot be explained by a lack of mRNA expression.
Absence of functional receptor may result from both poor expression and incorrect targeting.
To understand the reasons of receptor inactivity, immuno-cytofluorescence experiments were performed with some of the active and inactive clones, using the anti-flagM2 antibody. As shown in Fig. 5 , the signal obtained from clones expressing the pcDNA3-derived bigenic plasmid was not superior to naïve Gα16-CHO cells, whereas clones expressing functional receptors from bicistronic vectors provided a significant signal (Fig. 5A) . A selection of active or inactive clones expressing the bicistronic vector with VEGF IRES, all positive for NPY5R mRNA quantification (4800 to 10800 copies), were then analyzed. For the three active clones 7, 23 and 24, the NPY5-R was homogeneously detected in all the cells (Fig. 5B ), but the receptor seemed localized in the perinuclear granules. In contrast, for the inactive clone 11, the receptor expression was heterogeneous: part of the cells showed a very strong staining whereas no staining was detected in the other part of the cell population. In contrast to the active clones, the receptor was homogeneously detected in the cytoplasm of the stained cells.
This suggested that, in clones expressing the receptor mRNA but no functional NPY5-R, the receptor was not correctly targeted at the plasma membrane. (Table I) . Results show that the Ki's of the different ligands were similar to that obtained in transiently transfected cells, confirming that this clone is fully usable for pharmacological studies.
Long term expression and activity of NPY5-R in stable transfectants.
The cell line stability was tested with two clones expressing the transgenes with EMCV or VEGF IRES (Fig 8A) .
The results did not show any decrease in receptor activity after 49 and 51 passages, for EMCV and VEGF IRESs, respectively. In addition, the Bmax was measured up to 35 passages and did not reveal any loss of the binding capacity. These data show that bicistronic vectors allow a stable expression of transgenes under selection pressure, using both viral and cellular IRESs. Similar results were obtained with H4 receptor (data not shown).
DISCUSSION
The present study shows that bicistronic vectors, containing viral or cellular IRESs, allow the stable expression of functional receptors: NPY5-R and HH4R, and are thus vectors of choice to express active GPCRs with a high yield of positive clones. This study is the first one to compare bicistronic vectors (with IRESs) and bigenic vectors (with two promoters) and leads to a clear conclusion in favor of IRES-containing vectors. These experiments also demonstrate that cellular IRESs provide biotechnological tools, in addition to the widely used EMCV IRES, to express genes of interest in stable cell lines.
The expression of genes of interest often requires the co-expression of at least two proteins. In most cases, the gene of interest is expressed with a selection gene to introduce a selection pressure on the positive clones. Another requirement of gene co-expression is the necessity to express the two sub-units of a hetero-dimeric protein, as for IL-12 [23] .
Classically, the vectors used to express two genes simultaneously contain two promoters, each gene being controlled by a distinct transcription unit. Such vectors were successfully used in many cases, which explain their common use in cell transfection, including in our laboratory [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . However, the literature mostly reports successful experiments and is silent about the numerous failures encountered with such vectors, including in our laboratory. Indeed, a promoter interference phenomenon may occur and one has no guarantee of co-expression of both transgenes. Furthermore, the presence of the resistance gene on a transcription unit distinct from that expressing the gene of interest cannot ensure that the latter will be expressed by resistant cells. In particular, if the gene of interest has an inhibitory effect on cell proliferation or any other toxic effect, the selection pressure on a separate transcription unit is not able to prevent the counter-selection of the gene of interest, leading to resistant clones expressing only the resistance gene. In such a case, IRES-containing vectors may solve the problem, as the two genes of a bicistronic vector are controlled by the same transcription unit.
Our data demonstrate the advantage of the bicistronic vector in the case of two different GPCRs, the neuropeptide Y receptor 5 and the histamine receptor 4, for which our 'standard' procedure, successful in the past in numerous cases, was not able to provide us with stable cellular clones.
The reasons of pcDNA-3 derived vector inability to express significant amounts of receptor may be discussed. This vector has two transcription units controlled by CMV and SV40 promoters, respectively. This is not the only difference with the bicistronic vector: in both vectors the gene of interest is controlled by the CMV promoter, however in our bicistronic vector, we have introduced a small intron upstream from the first cistron coding sequence, since introns have been described for their ability to ensure higher transgene expression [28] . Thus, we cannot rule out a participation of this intron in the better expression Using the present system, we also showed the functionality of the NYP5 receptor, since the pharmacological data gathered with this system compare well with those reported on the other stable system available in the literature [15] or with our own data obtained, painfully, with the transiently expressed cells [4, 27, 30, 31] .
Our present data validated the use of bicistronic vectors to establish stable cell lines expressing counter-selected transgenes. Bicistronic vectors have been successfully used in previous reports, in particular for the expression of different FGF2 isoforms [32] or of the two interleukin 12 subunits together with the neo gene in a retrovirus vector [23] . More recently, a bicistronic adenovirus co-expressing VEGF and angiopoïetin 1 has shown a synergistic effect to produce functional and leak-resistant blood vessels by a myoblast-based cell therapy [33] .
The present study is the first one to provide a direct comparison of the advantage of IREScontaining vectors versus a two promoter-containing vector. In addition, most previously used bi-or tri-cistronic vectors contain the EMCV IRES exclusively, probably because commercial bicistronic vectors always bear the EMCV IRES. However, a set of other IRESs have been discovered and could be used to design new vectors. Among them, we can point out the retroviral IRESs which were used to construct retroviral vectors efficiently expressing reporter genes [34, 35] . As regards cellular IRESs, we have recently shown that the FGF2 IRES provides better results than the EMCV IRES to co-express co-stimulatory molecules in a retroviral vector [25] . In contrast, the present study shows that the FGF2 IRES, although able to produce stable clones with an acceptable yield, is the less efficient among the four IRESs tested. These data show that the cellular IRESs provide new tools to design bi-or multicistronic vectors, but the optimal IRES to be chosen may vary with the vector (plasmid, virus…), the cells to be transfected or the subtype of receptors.
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